Coproporphyrinogen III oxidase

Coproporphyrinogen III oxidase is an enzyme that plays a crucial role in the heme biosynthesis pathway. It catalyzes the oxidative decarboxylation of coproporphyrinogen III to form protoporphyrinogen IX, a key step in the production of heme.
Function[edit]
Coproporphyrinogen III oxidase is responsible for converting coproporphyrinogen III into protoporphyrinogen IX by removing two carboxyl groups from the propionate side chains of rings A and B of the porphyrin ring. This reaction is essential for the subsequent steps in the heme biosynthesis pathway, which ultimately lead to the formation of heme, an important component of hemoglobin, myoglobin, and various cytochromes.
Structure[edit]
The enzyme is typically a homodimer, with each subunit containing a flavin adenine dinucleotide (FAD) cofactor that is essential for its catalytic activity. The structure of coproporphyrinogen III oxidase has been elucidated through X-ray crystallography, revealing details about its active site and the binding of its substrate.
Mechanism[edit]
The enzymatic mechanism involves the oxidation of the methylene bridges of coproporphyrinogen III, facilitated by the FAD cofactor. This process results in the release of two molecules of carbon dioxide and the formation of protoporphyrinogen IX. The reaction is oxygen-dependent and occurs in the mitochondria of eukaryotic cells.
Clinical significance[edit]
Deficiencies in coproporphyrinogen III oxidase activity can lead to disorders such as hereditary coproporphyria, a type of porphyria characterized by the accumulation of porphyrin precursors. Symptoms of hereditary coproporphyria can include abdominal pain, neurological disturbances, and photosensitivity.
Heme biosynthesis pathway[edit]

Coproporphyrinogen III oxidase is part of the heme biosynthesis pathway, which involves multiple enzymatic steps starting from glycine and succinyl-CoA. The pathway includes the following steps:
1. Formation of δ-aminolevulinic acid (ALA) 2. Conversion of ALA to porphobilinogen 3. Formation of hydroxymethylbilane 4. Cyclization to form uroporphyrinogen III 5. Decarboxylation to form coproporphyrinogen III 6. Oxidation by coproporphyrinogen III oxidase to form protoporphyrinogen IX 7. Oxidation to form protoporphyrin IX 8. Insertion of iron to form heme
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian